Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Cell Stress & Chaperones
|
July 1, 2020
Correction to: COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
Philip L Hooper
Current Controlled Trials in Cardiovascular Medicine
|
January 25, 2002
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
Philip L Hooper
Cell Stress & Chaperones
|
June 6, 2020
COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
Philip L Hooper
Metabolic Syndrome and Related Disorders
|
March 29, 2008
Insulin Signaling, GSK-3, Heat Shock Proteins and the Natural History of Type 2 Diabetes Mellitus: A Hypothesis
Philip L Hooper
Cell Stress & Chaperones
|
August 23, 2008
Inflammation, heat shock proteins, and type 2 diabetes
Philip L Hooper, Paul L Hooper
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
June 19, 2016
Adequacy of the ophthalmology workforce under Ontario's Local Health Integration Networks
Tony Lin, Mark Xu, Philip L Hooper
Cell Stress & Chaperones
|
July 17, 2012
Loss of stress response as a consequence of viral infection: implications for disease and therapy
Philip L Hooper, Lawrence E Hightower, Paul L Hooper
Ophthalmology
|
December 7, 2007
Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial
Varun Chaudhary, Alex Mao, Philip L Hooper, et al.
Cell Stress & Chaperones
|
June 5, 2010
Xenohormesis: health benefits from an eon of plant stress response evolution
Philip L Hooper, Paul L Hooper, Michael Tytell, et al.
Cell Stress & Chaperones
|
February 14, 2014
The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes
Philip L Hooper, Gabor Balogh, Eric Rivas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Cell Stress & Chaperones
|
July 1, 2020
Correction to: COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
Philip L Hooper
Current Controlled Trials in Cardiovascular Medicine
|
January 25, 2002
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
Philip L Hooper
Cell Stress & Chaperones
|
June 6, 2020
COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
Philip L Hooper
Metabolic Syndrome and Related Disorders
|
March 29, 2008
Insulin Signaling, GSK-3, Heat Shock Proteins and the Natural History of Type 2 Diabetes Mellitus: A Hypothesis
Philip L Hooper
Cell Stress & Chaperones
|
August 23, 2008
Inflammation, heat shock proteins, and type 2 diabetes
Philip L Hooper, Paul L Hooper
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
June 19, 2016
Adequacy of the ophthalmology workforce under Ontario's Local Health Integration Networks
Tony Lin, Mark Xu, Philip L Hooper
Cell Stress & Chaperones
|
July 17, 2012
Loss of stress response as a consequence of viral infection: implications for disease and therapy
Philip L Hooper, Lawrence E Hightower, Paul L Hooper
Ophthalmology
|
December 7, 2007
Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial
Varun Chaudhary, Alex Mao, Philip L Hooper, et al.
Cell Stress & Chaperones
|
June 5, 2010
Xenohormesis: health benefits from an eon of plant stress response evolution
Philip L Hooper, Paul L Hooper, Michael Tytell, et al.
Cell Stress & Chaperones
|
February 14, 2014
The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes
Philip L Hooper, Gabor Balogh, Eric Rivas, et al.
Page
of 3